Membranous glomerulonephritis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{SAH}} | {{CMG}}; {{AE}} {{SAH}} | ||
==Overview== | ==Overview== | ||
The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000. | The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000. The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide. In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000. The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years. Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population. Membranous glomerulonephritis affects men and women equally. Membranous glomerulonephritis tends to affect Caucasian population and Chinese population. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* The membranous | * The membranous glomerulonephritis is a rare disease.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref> | *The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid24715030" /> | *The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid24715030" /> | ||
===Mortality rate=== | ===Mortality rate=== | ||
*In 2001, the | *In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000<ref name="McGroganFranssen2010" /><ref name="pmid24715030" /><ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref> | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop membranous glomerulonephritis | *Patients of all age groups may develop membranous glomerulonephritis | ||
*The incidence of | *The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years<ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref> | ||
===Race=== | ===Race=== | ||
* | *Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref> | ||
===Gender=== | ===Gender=== | ||
| Line 34: | Line 30: | ||
===Region=== | ===Region=== | ||
* Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref> | * Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref>\ | ||
=== | |||
=== | |||
==References== | ==References== | ||
| Line 45: | Line 37: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category:Nephrology]] | |||
[[Category:Up-to-date]] | |||
Latest revision as of 22:41, 29 July 2020
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics |
|
FDA on Membranous glomerulonephritis epidemiology and demographics |
|
CDC on Membranous glomerulonephritis epidemiology and demographics |
|
Membranous glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Membranous glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000. The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide. In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000. The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years. Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population. Membranous glomerulonephritis affects men and women equally. Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.
Epidemiology and Demographics
Incidence
- The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.[1]
Prevalence
- The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.[1][3]
Mortality rate
- In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000[1][3][4]
Age
- Patients of all age groups may develop membranous glomerulonephritis
- The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years[5]
Race
- Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population.[3][5]
Gender
- Membranous glomerulonephritis affects men and women equally.[3]
Region
References
- ↑ 1.0 1.1 1.2 1.3 McGrogan, A.; Franssen, C. F. M.; de Vries, C. S. (2010). "The incidence of primary glomerulonephritis worldwide: a systematic review of the literature". Nephrology Dialysis Transplantation. 26 (2): 414–430. doi:10.1093/ndt/gfq665. ISSN 0931-0509.
- ↑ Cattran DC, Brenchley PE (March 2017). "Membranous nephropathy: integrating basic science into improved clinical management". Kidney Int. 91 (3): 566–574. doi:10.1016/j.kint.2016.09.048. PMID 28065518.
- ↑ 3.0 3.1 3.2 3.3 3.4 Debiec H, Ronco P (July 2014). "Immunopathogenesis of membranous nephropathy: an update". Semin Immunopathol. 36 (4): 381–97. doi:10.1007/s00281-014-0423-y. PMID 24715030.
- ↑ Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF (December 2016). "Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China". J. Am. Soc. Nephrol. 27 (12): 3739–3746. doi:10.1681/ASN.2016010093. PMC 5118492. PMID 27365535.
- ↑ 5.0 5.1 5.2 Tang, Lijun; Yao, Jing; Kong, Xianglei; Sun, Qing; Wang, Zunsong; Zhang, Ying; Wang, Ping; Liu, Yipeng; Li, Wenbin; Cui, Meiyu; Zhen, Junhui; Xu, Dongmei (2017). "Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China". Nephrology. 22 (2): 168–173. doi:10.1111/nep.12739. ISSN 1320-5358.